日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Epithelial Regnase-1 inhibits colorectal tumor growth by regulating IL-17 signaling via degradation of NFKBIZ mRNA

上皮细胞Regnase-1通过降解NFKBIZ mRNA来调节IL-17信号通路,从而抑制结直肠肿瘤生长。

Iguchi, Eriko; Takai, Atsushi; Oe, Natsumi; Fujii, Yosuke; Omatsu, Mayuki; Takeda, Haruhiko; Shimizu, Takahiro; Maruno, Takahisa; Nakanishi, Yuki; Yoshinaga, Masanori; Maruyama, Takashi; Marusawa, Hiroyuki; Obama, Kazutaka; Takeuchi, Osamu; Seno, Hiroshi

First-Line Lenvatinib plus Pembrolizumab for Hepatocellular Carcinoma: Post hoc Analysis of Japanese Patients from the Phase 3 LEAP-002 Trial

一线使用乐伐替尼联合帕博利珠单抗治疗肝细胞癌:LEAP-002 III期试验中日本患者的事后分析

Kudo, Masatoshi; Ikeda, Masafumi; Aikata, Hiroshi; Numata, Kazushi; Marusawa, Hiroyuki; Hosaka, Tetsuya; Kato, Naoya; Kurosaki, Masayuki; Morimoto, Manabu; Yamashita, Tatsuya; Koga, Hironori; Masaki, Tsutomu; Yatsuzuka, Naoyoshi; Suzuki, Masato; Nagao, Satoshi; Kaneko, Shuichi; Kumada, Hiromitsu

Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy

乐伐替尼治疗前蛋白尿对阿特珠单抗联合贝伐珠单抗治疗反应的影响

Ochi, Hironori; Kurosaki, Masayuki; Tanaka, Takaaki; Tamaki, Nobuharu; Tsuchiya, Kaoru; Yasui, Yutaka; Marusawa, Hiroyuki; Tada, Toshifumi; Nakamura, Shinichiro; Akahane, Takehiro; Okamoto, Eisuke; Kobashi, Haruhiko; Arai, Hirotaka; Nonogi, Michiko; Izumi, Namiki

Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning

利用自动化机器学习进行全面的血清 miRNA 测序,实现胰腺癌的早期检测

Munenori Kawai ,Akihisa Fukuda ,Ryo Otomo ,Shunsuke Obata ,Kosuke Minaga ,Masanori Asada ,Atsushi Umemura ,Yoshito Uenoyama ,Nobuhiro Hieda ,Toshihiro Morita ,Ryuki Minami ,Saiko Marui ,Yuki Yamauchi ,Yoshitaka Nakai ,Yutaka Takada ,Kozo Ikuta ,Takuto Yoshioka ,Kenta Mizukoshi ,Kosuke Iwane ,Go Yamakawa ,Mio Namikawa ,Makoto Sono ,Munemasa Nagao ,Takahisa Maruno ,Yuki Nakanishi ,Mitsuharu Hirai ,Naoki Kanda ,Seiji Shio ,Toshinao Itani ,Shigehiko Fujii ,Toshiyuki Kimura ,Kazuyoshi Matsumura ,Masaya Ohana ,Shujiro Yazumi ,Chiharu Kawanami ,Yukitaka Yamashita ,Hiroyuki Marusawa ,Tomohiro Watanabe ,Yoshito Ito ,Masatoshi Kudo ,Hiroshi Seno

CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study

CRAFITY评分作为肝细胞癌患者对阿特珠单抗联合贝伐珠单抗治疗耐药性的预测指标:一项多中心回顾性研究

Ueno, Masayuki; Takeda, Haruhiko; Takai, Atsushi; Morimura, Hiroki; Nishijima, Norihiro; Iwamoto, Satoru; Okuyama, Shunsuke; Umeda, Makoto; Seta, Takeshi; Ikeda, Atsuyuki; Goto, Tomoyuki; Miyamoto, Shin'ichi; Kayahara, Takahisa; Uenoyama, Yoshito; Matsumura, Kazuyoshi; Nakano, Shigeharu; Mishima, Masako; Inuzuka, Tadashi; Eso, Yuji; Takahashi, Ken; Marusawa, Hiroyuki; Osaki, Yukio; Hatano, Etsuro; Seno, Hiroshi

Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study

出版商更正:CRAFITY评分作为肝细胞癌患者对阿特珠单抗联合贝伐珠单抗治疗耐药性的预测指标:一项多中心回顾性研究

Ueno, Masayuki; Takeda, Haruhiko; Takai, Atsushi; Morimura, Hiroki; Nishijima, Norihiro; Iwamoto, Satoru; Okuyama, Shunsuke; Umeda, Makoto; Seta, Takeshi; Ikeda, Atsuyuki; Goto, Tomoyuki; Miyamoto, Shin'ichi; Kayahara, Takahisa; Uenoyama, Yoshito; Matsumura, Kazuyoshi; Nakano, Shigeharu; Mishima, Masako; Inuzuka, Tadashi; Eso, Yuji; Takahashi, Ken; Marusawa, Hiroyuki; Osaki, Yukio; Hatano, Etsuro; Seno, Hiroshi

Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study

治疗周期对格卡瑞韦和哌仑他韦治疗慢性丙型肝炎疗效的影响:一项全国性、前瞻性、多中心研究

Morita, Atsuhiro; Tamaki, Nobuharu; Kobashi, Haruhiko; Mori, Nami; Tsuji, Keiji; Takaki, Shintaro; Hasebe, Chitomi; Akahane, Takehiro; Ochi, Hironori; Mashiba, Toshie; Urawa, Naohito; Fujii, Hideki; Mitsuda, Akeri; Kondo, Masahiko; Ogawa, Chikara; Uchida, Yasushi; Narita, Ryoichi; Marusawa, Hiroyuki; Kubotsu, Yoshihito; Matsushita, Tomomichi; Shigeno, Masaya; Yoshida, Hideo; Tanaka, Katsuaki; Okamoto, Eisuke; Kasai, Toyotaka; Ishii, Toru; Okada, Kazuhiko; Kurosaki, Masayuki; Izumi, Namiki

Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab

接受纳武利尤单抗治疗的晚期或复发性食管鳞状细胞癌的炎症预后因素

Ikoma, Tatsuki; Shimokawa, Mototsugu; Matsumoto, Toshihiko; Boku, Shogen; Yasuda, Tomoyo; Shibata, Nobuhiro; Kurioka, Yusuke; Takatani, Masahiro; Nobuhisa, Tetsuji; Namikawa, Tsutomu; Kitagawa, Hiroyuki; Hanazaki, Kazuhiro; Doi, Keitaro; Shimada, Takanobu; Tsumura, Takehiko; Marusawa, Hiroyuki; Kanaya, Seichiro; Morita, Shuko; Inokuma, Tetsurou; Nagai, Hiroki; Yasui, Hisateru; Satake, Hironaga

Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing

通过单分子实时测序确定HBV基因组在持续感染过程中的进化转变

Arasawa, Soichi; Takeda, Haruhiko; Takai, Atsushi; Iguchi, Eriko; Eso, Yuji; Shimizu, Takahiro; Takahashi, Ken; Yamashita, Taiki; Ueda, Yoshihide; Marusawa, Hiroyuki; Seno, Hiroshi

Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response

对于已获得持续病毒学应答的慢性丙型肝炎老年患者,有必要进行肝细胞癌监测。

Ishido, Shun; Tamaki, Nobuharu; Kurosaki, Masayuki; Mori, Nami; Tsuji, Keiji; Hasebe, Chitomi; Mashiba, Toshie; Ochi, Hironori; Yasui, Yutaka; Akahane, Takehiro; Furuta, Koichiro; Kobashi, Haruhiko; Fujii, Hideki; Ishii, Toru; Marusawa, Hiroyuki; Kondo, Masahiko; Kusakabe, Atsunori; Yoshida, Hideo; Uchida, Yasushi; Tada, Toshifumi; Nakamura, Shinichiro; Mitsuda, Akari; Ogawa, Chikara; Arai, Hirotaka; Murohisa, Toshimitsu; Uebayashi, Minoru; Izumi, Namiki